ARK Diagnostics, Inc. products

The ARK Linezolid Assay is intended for the quantitative determination of linezolid in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of linezolid to help ensure appropriate therapy.

The ARK Voriconazole II Assay is intended for the quantitative determination of voriconazole in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of voriconazole to help ensure appropriate therapy.

The ARK Efavirenz Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of efavirenz in human serum or plasma on automated clinical chemistry analyzers. The serum or plasma concentration of efavirenz, used in combination with other clinical information, may aid in the management of patients treated with efavirenz. Measurements of efavirenz are intended to help ensure appropriate therapy or to monitor adherence.

The ARK Methotrexate Assay is intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of methotrexate to help ensure appropriate therapy.

The ARK™ Lamotrigine Assay is intended for the quantitative determination of Lamotrigine in human serum or plasma on automated clinical chemistry analyzers. Lamotrigine concentrations can be used as an aid in management of patients treated with lamotrigine.